Latest News

A new study shows that better prostate cancer treatments could reach men almost two years sooner than is currently possible.
Long-term follow-up results from the PIVOT trial confirm that protease inhibitor monotherapy preserves future drug options as well as standard combination therapy.
For our 25th anniversary celebrations, we explore the PRACTical trial design, which allows researchers to compare multiple treatments for diseases that don’t have a single “standard-of-care” treatment.
This new route will allow to study part-time as part of an integrated apprenticeship, providing the level 7 qualification as a medical statistician.
H-PRIME will investigate the best way to treat sickle cell disease in Ugandan children using a factorial trial design.